The Effect of Experimental Neck Pain in Healthy Participants

February 19, 2019 updated by: Steffan Wittrup Christensen, Aalborg University

The Effect of Experimental Neck Pain in Healthy Participants - The Transition From Acute to Ongoing Pain

This study investigates if/how an experimentally applied muscle pain/soreness, lasting for some days may affect brain activity, balance, movement patterns, muscle function and pain sensitivity in a healthy population

Study Overview

Status

Unknown

Conditions

Detailed Description

All included healthy volunteers will participate in test-sessions on 4 separate days over approximately 2 weeks.

During the study participants will be randomised into and either a control group (injection of isotonic saline into a neck muscle) or neck pain group (injection of Nerve Growth Factor (NGF) into a neck muscle).

Alle participants tested with regards to:

Brain activity related to neck muscles will be estimated using TMS Balance will be tested using a force place Body movements will be recorded using 3D tracking Muscle activity will be estimated using electromyography (EMG)

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aalborg, Denmark, 9220
        • Recruiting
        • Dept. Of Health Science and Technology, SMI, Aalborg University
        • Contact:
          • Steffan W Christensen, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 46 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy men and women aged 18-50 years
  • Only for sub-projects 1 and 2: Right-handed
  • Able to speak, read and understand Danish and English

Exclusion Criteria:

  • Pain from the neck or shoulder area during the past 6 months
  • Experience of delayed onset muscle soreness (DOMS) during the week leading up to the test session
  • Former surgery in neck or shoulder
  • Current or previous chronic or recurrent pain condition
  • Pregnancy
  • Drug addiction defined as the use of cannabis, opioids or other drugs
  • Previous neurologic, musculoskeletal or mental illnesses
  • Regular use of analgesics
  • Abnormally disrupted sleep in the last 24 hours preceding the experiment
  • Lack of ability to cooperate
  • Unable to pass the TASS safety screening questionnaire for TMS

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Control group
Participants will be injected with 0.5ml Isotonic saline into a neck muscle
Half the participants will be injected in a neck muscle with isotonic saline (Control group) and the other half will get NGF (Neck pain group).
Experimental: Neck pain
Participants will be injected with 0.5ml NGF into the a neck muscle
Half the participants will be injected in a neck muscle with NGF (Neck pain group).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pressure pain threshold (PPT) measured with a handheld pressure algometer
Time Frame: Day 0, 2,4 and 15
PPT will be assessed over head, neck, arm and leg sites.
Day 0, 2,4 and 15
Change in motor evoked potentials
Time Frame: Day 0, 4 and 15
Trans cranial magnetic stimulation (TMS) is used to asses motor evoked potentials of neck muscles
Day 0, 4 and 15
Change in Body movement
Time Frame: Day 0, 4 and 15
3D recordings of body movements
Day 0, 4 and 15

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in muscle activity (EMG)
Time Frame: Day 0, 4 and 15
EMG of axioscapular muscles & trunk during arm movements
Day 0, 4 and 15
Change in standing balance
Time Frame: Day 0, 4 and 15
Standing balance is measured on a force platform
Day 0, 4 and 15
Change in perceived pain: McGill Pain Questionnaire
Time Frame: Day 0, 2,4 and 15
Pain will be scored using a scale from 0-10 with 0 being no pain and 10 being worst imaginable pain, by drawing on body charts and choosing words from the McGill Pain Questionnaire.
Day 0, 2,4 and 15
Disability
Time Frame: Day 0, 2,4 and 15
Neck disability Index will be scored. Body movements will be scored on a modified 6-point Likert scale (0 = not difficult at all; 1 = minimally difficult; 2 = somewhat difficult; 3 = fairly difficult; 4 = very difficult; 5 = unable to perform)
Day 0, 2,4 and 15
Pain Catastrophizing Scale (13 item questionnaire)
Time Frame: Day 2

Pain Catastrophizing Scale (PCS) questionnaire. 13 items that can be answered with a Likert scale (0 = not at all, 1 = to a slight degree, 2= to a moderate degree, 3 = to a great degree, 4 = all the time).

The PCS is scored by summing responses to all 13 items with scores ranging from 0 - 52.

Day 2
The Big Five Inventory (BFI)
Time Frame: Day 2
BFI questionnaire investigates five general traits personality: extraversion, agreeableness, conscientiousness, neuroticism and openness. The BFI consists of 44 items that are answered on a 5 point Likert scale (1=Disagree strongly, 2=Disagree a little, 3=Neither agree or disagree, 4=Agree a little, 5=Agree strongly). This is not good/bad score in this questionnaire as it only assess personality traits.
Day 2

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 21, 2019

Primary Completion (Anticipated)

May 1, 2019

Study Completion (Anticipated)

May 1, 2019

Study Registration Dates

First Submitted

February 16, 2019

First Submitted That Met QC Criteria

February 19, 2019

First Posted (Actual)

February 20, 2019

Study Record Updates

Last Update Posted (Actual)

February 21, 2019

Last Update Submitted That Met QC Criteria

February 19, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • N-20180063_Sub-project_1

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Injection of Isotonic saline

Subscribe